Survey of Ophthalmology
Volume 47, Issue 1 , Pages 1-16 , January 2002

Risk Factors for Metastasis in Retinoblastoma

  • Paul T Finger, MD

      Affiliations

    • The New York Eye Cancer Center, New York, NY USA
    • Corresponding Author InformationReprint address: Paul T. Finger, MD, The New York Eye Cancer Center, 115 East 61st Street, New York, New York, 10021
    • ,
  • J.William Harbour, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO USA
    • ,
  • Zeynel A Karcioglu, MD

      Affiliations

    • Department of Ophthalmology, Tulane University Medical School and Cancer Center, New Orleans, LA, USA

References 

  1. Abramson DH, Ellsworth RM. The surgical management of retinoblastoma. Ophthalmic Surg. 1980;11:596–598
  2. Abramson DH, Ellsworth RM, Grumbach N, Kitchin FD. Retinoblastoma (survival, age at detection and comparison 1914–1958, 1958–1983). J Pediatr Ophthalmol Strabismus. 1985;22:246–250
  3. Abramson DH, Ellsworth RM, Tretter P, et al.  Treatment of bilateral groups I through III retinoblastoma with bilateral radiation. Arch Ophthalmol. 1981;99:1761–1762
  4. Abramson DH, Greenfield DS, Ellsworth RM. Bilateral retinoblastoma. Correlations between age at diagnosis and time course for new intraocular tumors. Ophthalmic Paediatr Genet. 1992;13:1–7
  5. Abramson DH, Niksarli K, Ellsworth RM, Servodidio CA. Changing trends in the management of retinoblastoma (1951–1965 vs 1966–1980). J Pediatr Ophthalmol Strabismus. 1994;31:32–37
  6. Ainbinder DJ, Haik BG, Frei DF, et al.  Gadolinium enhancement (improved MRI detection of retinoblastoma extension into the optic nerve). Neuroradiology. 1996;38:778–781
  7. Albert DM, Craft J, Sang DN. Ultrastructural retinoblastoma (transmission and scanning electron microscopy). In:  Jakobiec FA editors. Ocular and Adnexal Tumors. Birmingham, AL: Aesculapius; 1978;p. 157–171
  8. Amati B, Alevizopoulos K, Vlach J. Myc and the cell cycle. Front Biosci. 1998;3:D250–D268
  9. Bader JL, Meadows AT, Zimmerman LE, et al.  Bilateral retinoblastoma with ectopic intracranial retinoblastoma (trilateral retinoblastoma). Cancer Genet Cytogenet. 1982;5:203–213
  10. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res. 1997;237:1–6
  11. Blach LE, McCormick B, Abramson DH, Ellsworth RM. Trilateral retinoblastoma—incidence and outcome (a decade of experience). Int J Radiat Oncol Biol Phys. 1994;29:729–733
  12. Burnier MN, McLean IW, Zimmerman LE, Rosenberg SH. Retinoblastoma. The relationship of proliferating cells to blood vessels. Invest Ophthalmol Vis Sci. 1990;31:2037–2040
  13. Cano J, Oliveros O, Yunis E. Phenotype variants, malignancy, and additional copies of 6p in retinoblastoma. Cancer Genet Cytogenet. 1994;76:112–115
  14. Carbajal UM. Metastasis in retinoblastoma. Am J Ophthalmol. 1959;48:47–69
  15. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour- suppressor gene. Trends Biochem Sci. 1999;24:73–76
  16. Coupland SE, Bechrakis N, Schuler A, et al.  Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br J Ophthalmol. 1998;82:961–970
  17. de Sutter E, Havers W, Hopping W, et al.  The prognosis of retinoblastoma in terms of survival. A computer assisted study. Part II. Ophthalmic Paediatr Genet. 1987;8:85–88
  18. DeBuen S. Retinoblastoma with spread by direct continuity to the contralateral optic nerve (report of a case). Am J Ophthalmol. 1960;49:815–819
  19. DerKinderen DJ, Koten JW, Van Romunde LK, et al.  Early diagnosis of bilateral retinoblastoma reduces death and blindness. Int J Cancer. 1989;44:35–39
  20. Devesa SS. The incidence of retinoblastoma. Am J Ophthalmol. 1975;80:263–265
  21. Donoso LA, Rorke LB, Shields JA, et al.  S-antigen immunoreactivity in trilateral retinoblastoma. Am J Ophthalmol. 1987;103:57–62
  22. Doz F, Khelfaoui F, Mosseri V, et al.  The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with. 1994;33(patients. Cancer 74):722–732
  23. Doz F, Peter M, Schleiermacher G, et al.  N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma. Eur J Cancer. 1996;32A:645–649
  24. Ellsworth RM. Orbital retinoblastoma. Trans Am Ophthalmol Soc. 1974;72:79–88
  25. Ellsworth RM. The treatment of retinoblastoma. Bibl Ophthalmol. 1968;75:142–148
  26. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet. 1989;10:179–184
  27. Finger PT, Czechonska G, Demirci H, Rausen A. Chemotherapy for retinoblastoma (a current topic). Drugs. 1999;58:983–996
  28. Finger, PT, Murphree AL: Ophthalmic brachytherapy: treatment of choroidal melanoma and retinoblastoma. In: Peyman G, Meffert S, Conway MD, Chou F (eds): Vitreoretinal Surgical Techniques London, Martin Dunitz, 2001, pp. 403–18.
  29. Friedman HS, Kurtzberg J, Croker B, et al.  Retinoblastoma metastatic to bone marrow. A case with florid spread. Clin Pediatr (Phila). 1984;23:184–187
  30. Friend SH, Bernards R, Rogelj S, et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643–646
  31. Fung YK, Murphree AL, Tang A, et al.  Structural evidence for the authenticity of the human retinoblastoma gene. Science. 1987;236:1657–1661
  32. Gallie BL, Budning A, DeBoer G, et al.  Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321–1328
  33. Gallie BL, Campbell C, Devlin H, et al.  Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 1999;59:1731s–1735s
  34. Gilbert F, Potluri VR, Short MP, et al.  Retinoblastoma, chromosome abnormalities and oncogene expression. Ophthalmic Paediatr Genet. 1987;8:3–10
  35. Gupta J, Han LP, Wang P, et al.  Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst. 1996;88:1152–1157
  36. Haik BG, Dunleavy SA, Cooke C, et al.  Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94:367–370
  37. Haik BG, Saint Louis L, Smith ME, et al.  Computed tomography of the nonrhegmatogenous retinal detachment in the pediatric patient. Ophthalmology. 1985;92:1133–1142
  38. Haik BG, Saint Louis L, Smith ME, et al.  Magnetic resonance imaging in the evaluation of leukocoria. Ophthalmology. 1985;92:1143–1152
  39. Haik BG, Siedlecki A, Ellsworth RM, Sturgis-Buckhout L. Documented delays in the diagnosis of retinoblastoma. Ann Ophthalmol. 1985;17:731–732
  40. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  41. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993;329:1318–1327
  42. Herkes HE, Manschot WA. The danger of diagnostic biopsy in eyes suspected of an intraocular tumor. Ophthalmologica. 1963;145:467–469
  43. Hopping W, Waubke TN, Sack H. Orbital involvement in retinoblastoma. Mod Probl Ophthalmol. 1975;14:382–387
  44. Hungerford J. Factors influencing metastasis in retinoblastoma. Br J Ophthalmol. 1993;77:541
  45. Hungerford J, Kingston J, Plowman N. Orbital recurrence of retinoblastoma. Ophthalmic Paediatr Genet. 1987;8:63–68
  46. Ibarra MS, OBrien JM. Is screening for primitive neuroectodermal tumors in patients with unilateral retinoblastoma necessary?. J AAPOS. 2000;4:54–56
  47. Jacquemin C, Karcioglu ZA. Detection of optic nerve involvement in retinoblastoma with enhanced computed tomography. Eye. 1998;12:179–183
  48. Karcioglu ZA, al-Mesfer SA, Abboud E, et al.  Workup for metastatic retinoblastoma. A review of. 1997;261(patients. Ophthalmology 104):307–312
  49. Karcioglu ZA, al-Mesfer SA, Mullaney PB. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology. 1998;105:1311–1316
  50. Karcioglu ZA, Al-Rasheed W, Abboud E. Clinical and histopathological features of retinoblastoma presenting in children older than 5 years of age. Invest Ophthalmol Vis Sci. 1989;39:S600
  51. Karcioglu ZA, Gordon RA, Karcioglu GL. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology. 1985;92:1763–1767
  52. Karcioglu ZA, Haik BG. Tissue Diagnosis (Intraocular Tumors). New York: McMillan; 1987;
  53. Karcioglu ZA, Haik BG, Gordon RA. Frozen section of the optic nerve in retinoblastoma surgery. Ophthalmology. 1988;95:674–676
  54. Karcioglu ZA, Huaman AM. Angiogenesis in retinoblastoma. Middle East J Ophthalmol. 1996;4:17–25
  55. Karcioglu ZA, Mullaney PB, Millar LC. Extrusion of porous polyethylene orbital implant in recurrent retinoblastoma. Ophthal Plast Reconstr Surg. 1998;14:37–44
  56. Karcioglu ZA, Parson Bamgboye E. Retinoblastoma angiogenesis and prognosis. Exp Eye Res. 1996;63:S69
  57. Khelfaoui F, Validire P, Auperin A, et al.  Histopathologic risk factors in retinoblastoma (a retrospective study of 172 patients treated in a single institution). Cancer. 1996;77:1206–1213
  58. Kiratli H, Bilgic S, Ozerdem U. Management of massive orbital involvement of intraocular retinoblastoma. Ophthalmology. 1988;105:322–326
  59. Kivela T. Trilateral retinoblastoma (a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma). J Clin Oncol. 1999;17:1829–1837
  60. Knudson AG. Mutation and cancer (statistical study of retinoblastoma). Proc Natl Acad Sci USA. 1971;68:820–823
  61. Knudson AG, Hethcote HW, Brown BW. Mutation and childhood cancer (a probabilistic model for the incidence of retinoblastoma). Proc Natl Acad Sci USA. 1975;72:5116–5120
  62. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371–377
  63. Kovanlikaya A, Nelson MD, Murphree AL. Radiological case of the month. Retinoblastoma presenting with orbital cellulitis. Arch Pediatr Adolesc Med. 1996;150:873–874
  64. Kvanta A, Steen B, Seregard S. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma. Exp Eye Res. 1996;63:511–518
  65. Lee WH, Bookstein R, Hong F, et al.  Human retinoblastoma susceptibility gene (cloning, identification, and sequence). Science. 1987;235:1394–1399
  66. Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature. 1984;309:458–460
  67. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217–222
  68. Marcus DM, Brooks SE, Leff G, et al.  Trilateral retinoblastoma (insights into histogenesis and management). Surv Ophthalmol. 1998;43:59–70
  69. McLean I. Retinobastoma, retinocytomas, and pseudoretinoblastomas. Philadelphia: Saunders; 1996;
  70. McLean IW, Rosenberg SH, Messmer EP, et al.  Prognostic factors in cases of retinoblastoma (analysis of 974 patients from Germany and the United States treated by enucleation). In:  Bornfeld N,  Gragoudas ES,  Hopping W editor. Tumors of the Eye. Amsterdam: Netherlands, Kugler; 1991;p. 69–72
  71. Meli FJ, Boccaleri CA, Manzitti J, Lylyk P. Meningeal dissemination of retinoblastoma (CT findings in eight patients). AJNR Am J Neuroradiol. 1990;11:983–986
  72. Merrium GR. Retinoblastoma analysis of 17 autopsies. Arch Ophthalmol. 1950;44:71–108
  73. Messmer EP, Heinrich T, Hopping W, et al.  Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98:136–141
  74. Moll AC, Kuik DJ, Bouter LM, et al.  Incidence and survival of retinoblastoma in The Netherlands (a register based study 1862–1995). Br J Ophthalmol. 1997;81:559–562
  75. Morgan G. Diffuse infiltrating retinoblastoma. Br J Ophthalmol. 1971;55:600–606
  76. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol. 2000;44:277–301
  77. Muir KR, Smith H, Parkes SE, et al.  Increasing incidence of retinoblastoma?. Arch Dis Child. 1990;65:915
  78. Mullaney PB, Karcioglu ZA, al-Mesfer S, Abboud EB. Presentation of retinoblastoma as phthisis bulbi. Eye. 1997;11:403–408
  79. Mullaney PB, Karcioglu ZA, Huaman AM, al-Mesfer S. Retinoblastoma associated orbital cellulitis. Br J Ophthalmol. 1998;82:517–521
  80. Murphree AL, Villablanca JG, Deegan WF, et al.  Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–1356
  81. Nicholson DH, Norton EW. Diffuse infiltrating retinoblastoma. Trans Am Ophthalmol Soc. 1980;78:265–289
  82. Nork TM, Poulsen GL, Millecchia LL, et al.  p53 regulates apoptosis in human retinoblastoma. Arch Ophthalmol. 1997;115:213–219
  83. Oliveros O, Yunis E. Chromosome evolution in retinoblastoma. Cancer Genet Cytogenet. 1995;82:155–160
  84. Peer J, Neufeld M, Baras M, et al.  Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology. 1997;104:1251–1258
  85. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol. 1980;98:1204–1210
  86. Pesin SR, Shields JA. Seven cases of trilateral retinoblastoma. Am J Ophthalmol. 1989;107:121–126
  87. Popoff N, Ellsworth RM. The fine structure of nuclear alterations in retinoblastoma and in the developing human retina (in vivo and in vitro observations). J Ultrastruct Res. 1969;29:535–549
  88. Pradhan DG, Sandridge AL, Mullaney P, et al.  Radiation therapy for retinoblastoma (a retrospective review of 120 patients). Int J Radiat Oncol Biol Phys. 1997;39:3–13
  89. Pratt CB, Meyer D, Chenaille P, Crom DB. The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma. J Clin Oncol. 1989;7:140–143
  90. Redler LD, Ellsworth RM. Prognostic importance of choroidal invasion in retinoblastoma. Arch Ophthalmol. 1973;90:294–296
  91. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–172
  92. Robertson DM, Campbell RJ. Analysis of misdiagnosed retinoblastoma in a series of 726 enucleated eyes. Mod Probl Ophthalmol. 1977;18:156–159
  93. Romanella A, Abramson DH, Servodidio CA. Unusual presenting signs of retinoblastoma (a case study). J Ophthalmic Nurs Technol. 1991;10:98–102
  94. Rootman J. Diseases of the Orbit. Philadelphia: Lippincott; 1988;
  95. Rootman J, Ellsworth RM, Hofbauer J, Kitchen D. Orbital extension of retinoblastoma (a clinicopathological study). Can J Ophthalmol. 1978;13:72–80
  96. Rootman J, Hofbauer J, Ellsworth RM, Kitchen D. Invasion of the optic nerve by retinoblastoma (a clinicopathological study). Can J Ophthalmol. 1976;11:106–114
  97. Rubenfeld M, Abramson DH, Ellsworth RM, Kitchin FD. Unilateral vs. bilateral retinoblastoma. Correlations between age at diagnosis and stage of ocular disease. Ophthalmology. 1986;93:1016–1019
  98. Rubin CM, Robison LL, Cameron JD, et al.  Intraocular retinoblastoma group V (an analysis of prognostic factors). J Clin Oncol. 1985;3:680–685
  99. Sanders TE, Smith ME. Biopsy of intraocular tumors (a reevaluation). Int Ophthalmol Clin. 1972;12:163–176
  100. Schiffman JS, Grunwald GB. Differential cell adhesion and expression of N-cadherin among retinoblastoma cell lines. Invest Ophthalmol Vis Sci. 1992;33:1568–1574
  101. Schilling H, Yang H, Havers W, et al: Changes of the RPE and choroidal invasion in 297 enucleated eyes with retinoblastoma, in IXth Symposium of the Retinoblastoma Society, Geneva, Switzerland, 1998
  102. Schipper J: Retinoblastoma: a medical and experimental study, in Radiation Oncology. Utrecht, Netherlands, University of Utrecht, 1980, pp 144
  103. Scott MH, Richard JM. Retinoblastoma in the state of Oklahoma (a clinicopathologic review). J Okla State Med Assoc. 1993;86:111–118
  104. Shields CL, Shields JA, Baez K, et al.  Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73:692–698
  105. Shields CL, Shields JA, Baez KA, et al.  Choroidal invasion of retinoblastoma (metastatic potential and clinical risk factors). Br J Ophthalmol. 1993;77:544–548
  106. Shields CL, Shields JA, Shah P. Retinoblastoma in older children. Ophthalmology. 1991;98:395–399
  107. Shields JA, Shields CL. Intraocular Tumors (A Text and Atlas). Philadelphia: Saunders; 1992;
  108. Shields JA, Shields CL, Donoso LA, Lieb WE. Changing concepts in the management of retinoblastoma. Ophthalmic Surg. 1990;21:72–76
  109. Shields JA, Shields CL, Sivalingam V. Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol. 1989;108:185–188
  110. Shields JA, Shields CL, Suvarnamani C, et al.  Retinoblastoma manifesting as orbital cellulitis. Am J Ophthalmol. 1991;112:442–449
  111. Skubitz AP, Grossman MD, McCarthy JB, et al.  The decreased adhesion of Y79 retinoblastoma cells to extracellular matrix proteins is due to a deficit of integrin receptors. Invest Ophthalmol Vis Sci. 1994;35:2820–2833
  112. Squire J, Phillips RA, Boyce S, et al.  Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma (verification by standard staining techniques, new densitometric methods, and somatic cell hybridization). Hum Genet. 1984;66:46–53
  113. Stafford WR, Yanoff M, Parnell BL. Retinoblastomas initially misdiagnosed as primary ocular inflammations. Arch Ophthalmol. 1969;82:771–773
  114. Stanford GB, Reese AB. Malignant cells in the blood of eye patients. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:102–109
  115. Stannard C, Lipper S, Sealy R, Sevel D. Retinoblastoma (correlation of invasion of the optic nerve and choroid with prognosis and metastases). Br J Ophthalmol. 1979;63:560–570
  116. Svedberg-Winholt H, Al-Moster SA, Riley FC: Survival trends of retinoblastoma patients with extraocular extension. Congress of European Society of Ophthalmology Abstract: 502, 1999
  117. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States (1974 through 1985). Arch Ophthalmol. 1990;108:128–132
  118. Tso MO, Fine BS, Zimmerman LE. The nature of retinoblastoma. II. Photoreceptor differentiation (an electron microscopic study). Am J Ophthalmol. 1970;69:350–359
  119. Tso MO, Zimmerman LE, Fine BS. The nature of retinoblastoma. I. Photoreceptor differentiation (a clinical and histopathologic study). Am J Ophthalmol. 1970;69:339–349
  120. Tso MO, Zimmerman LE, Fine BS, Ellsworth RM. A cause of radioresistance in retinoblastoma (photoreceptor differentiation). Trans Am Acad Ophthalmol Otolaryngol. 1970;74:959–969
  121. Urquidi V, Tarin D, Goodison S. Role of telomerase in cell senescence and oncogenesis. Annu Rev Med. 2000;51:65–79
  122. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  123. Yanoff M, Fine BS. Ocular Pathology. New York: Harper and Row; 1984;

PII: S0039-6257(01)00279-X

Survey of Ophthalmology
Volume 47, Issue 1 , Pages 1-16 , January 2002

Article Tools

* Image Usage & Resolution